Progress and prospects: nuclear import of nonviral vectors.
about
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseNucleic acid delivery: the missing pieces of the puzzle?Micelle-like nanoparticles as carriers for DNA and siRNARemnant living cells that escape cell loss in late-stage tumors exhibit cancer stem cell-like characteristicsNew insights into the mechanisms of gene electrotransfer--experimental and theoretical analysisEfficacy and mechanism of poloxamine-assisted polyplex transfectionBioreducible polymers for therapeutic gene deliveryStoichiometric incorporation of base substitutions at specific sites in supercoiled DNA and supercoiled recombination intermediatesIntracellular trafficking of polyamidoamine-poly(ethylene glycol) block copolymers in DNA delivery.BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector.Retrohoming of a Mobile Group II Intron in Human Cells Suggests How Eukaryotes Limit Group II Intron ProliferationIn vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivoVector Design for Improved DNA Vaccine Efficacy, Safety and Production.Nanoparticle-based technologies for retinal gene therapyFluorogenic Substrates for In Situ Monitoring of Caspase-3 Activity in Live CellsCharacterization of exogenous DNA mobility in live cells through fluctuation correlation spectroscopy.DNA Targeting Sequence Improves Magnetic Nanoparticle-Based Plasmid DNA Transfection Efficiency in Model Neurons.LNA-based oligonucleotide electrotransfer for miRNA inhibition.Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.Polyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Gene therapy for ALI/ARDS.Intradermal naked plasmid DNA immunization: mechanisms of action.Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.Noninvasive cell-tracking methods.SPECT and PET to optimize cardiac stem cell therapy.Cancer imaging: Gene transcription-based imaging and therapeutic systems.Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Expert opinion in biological therapy: update on developments in lung gene transfer.The role of cell cycle in the efficiency and activity of cancer nanomedicines.Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells.New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.Minicircle DNA vectors for gene therapy: advances and applications.Synthetic biology devices and circuits for RNA-based 'smart vaccines': a propositional review.Nanomedicine for gene therapy.Shaping of interphase chromosomes by the microtubule network.Factors influencing the nuclear targeting ability of nuclear localization signals.In vitro gene manipulation of spinal muscular atrophy fibroblast cell line using gene-targeting fragment for restoration of SMN protein expression.Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
P2860
Q26752578-CD11077B-9BB5-476A-8DDE-012F3F169FD5Q26851886-417D82C8-0198-4C25-AB2E-758A8A6B0175Q27001558-331BE595-248D-4BA0-9FDA-E294ED0C4406Q30526491-3692D725-86EF-4BCF-80C2-CFCB3CEB9751Q33562379-41CA3A13-33F2-4F50-BEF2-356DB2AA8693Q33858972-6A336770-2CC4-4007-A7CE-34E449DF88D2Q34079568-B8E339D0-30FA-4C00-B48C-19690F44B4D5Q34189353-E86D203B-1A8B-4304-8866-0FB6222E0B87Q35555581-79089763-BDB7-483A-BD5F-15FE50D08B70Q35572475-AEF41ADF-7053-4CC1-B1B1-4096707D1F61Q35737495-A9A070C3-B1B3-4832-A8C7-39B78BE6DFF0Q35802123-EA72196F-A117-4106-8025-5F6FE49E3370Q35826665-242B0769-F139-4D55-B65D-0F470BA55FA9Q35843512-4A86B81D-5730-47F9-A92E-A8E94D9373BEQ36014569-53BC94BA-1CE3-49AC-8051-5B70B7FF8B15Q36044149-1B9213D8-1340-4E56-8AED-885EC748A105Q36088691-96617A37-02BC-4945-AE1B-B474554BD2A1Q36142470-F16D0604-44EF-402F-B072-24052EB9855DQ36474508-3A1F25E8-4218-47CA-A0A2-EB3E103CB80CQ36673747-AC8C2F52-B0B8-42B1-85F6-5A57637F6294Q36798836-D5D0A6AE-4C3E-4E62-9B8A-BBB2F6727717Q37849777-0BF9371D-4485-4F5A-B0CA-E7496C5D23B1Q37899551-9FE4012F-970C-4B3F-A4FF-F0F21DF13FADQ37919894-487FBDD6-E36B-4496-92A4-E287924A7CB9Q37925857-1E156B32-3DAE-47D4-93A5-C32AA8FF6E7BQ37938642-8265AAD1-0026-4522-9D3F-497BC6BED642Q37975993-34EBBED5-08F7-439F-93B1-3A38699A0D20Q37986315-85360FC2-FC7D-48AF-9B03-019DAAFCB49AQ38028961-33377F1B-AAA3-418D-8388-CD3BDBA31925Q38071683-313650D6-D715-4760-ACD4-734C639EC825Q38084705-BE68B33F-C479-44B3-806E-CB17721C9A16Q38097918-4AA2C1D4-EFB3-47F1-928F-070E5D2B908CQ38183853-D2D3560D-6BEB-4F99-A4BB-96984463EE36Q38300052-F9BEDD7E-2F62-4DEA-8DBD-81E0C9E2E2F1Q38310499-0B5376CA-232E-4F8C-9B40-C3649982DF7DQ38383478-13B7E891-24C3-4C66-AD85-C76528177C11Q38514865-E2022CBA-D878-456F-B335-930A4FE5D641Q38820534-8D20019A-0342-4D92-B457-3CC65EBB20BCQ38838690-F98166A8-E949-4756-99FB-62ECB8D59BC9Q38913162-D759B9E6-FF74-4A2B-B291-1959B788E000
P2860
Progress and prospects: nuclear import of nonviral vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress and prospects: nuclear import of nonviral vectors.
@en
Progress and prospects: nuclear import of nonviral vectors.
@nl
type
label
Progress and prospects: nuclear import of nonviral vectors.
@en
Progress and prospects: nuclear import of nonviral vectors.
@nl
prefLabel
Progress and prospects: nuclear import of nonviral vectors.
@en
Progress and prospects: nuclear import of nonviral vectors.
@nl
P2860
P356
P1433
P1476
Progress and prospects: nuclear import of nonviral vectors.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2010.31
P577
2010-03-04T00:00:00Z